199 related articles for article (PubMed ID: 23475484)
1. [NKT cells: their development, mechanisms and effects of action].
Bojarska-Junak A; Tabarkiewicz J; Roliński J
Postepy Hig Med Dosw (Online); 2013 Feb; 67():65-78. PubMed ID: 23475484
[TBL] [Abstract][Full Text] [Related]
2. Natural killer T cells in health and disease.
Wu L; Van Kaer L
Front Biosci (Schol Ed); 2011 Jan; 3(1):236-51. PubMed ID: 21196373
[TBL] [Abstract][Full Text] [Related]
3. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
Gerth E; Mattner J
Front Immunol; 2019; 10():1449. PubMed ID: 31293596
[TBL] [Abstract][Full Text] [Related]
4. Artificial antigen presenting cell (aAPC) mediated activation and expansion of natural killer T cells.
East JE; Sun W; Webb TJ
J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299308
[TBL] [Abstract][Full Text] [Related]
5. Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.
Venkataswamy MM; Porcelli SA
Semin Immunol; 2010 Apr; 22(2):68-78. PubMed ID: 19945296
[TBL] [Abstract][Full Text] [Related]
6. The ins and outs of type I iNKT cell development.
Shissler SC; Webb TJ
Mol Immunol; 2019 Jan; 105():116-130. PubMed ID: 30502719
[TBL] [Abstract][Full Text] [Related]
7. Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.
Almeida CF; Sundararaj S; Le Nours J; Praveena T; Cao B; Burugupalli S; Smith DGM; Patel O; Brigl M; Pellicci DG; Williams SJ; Uldrich AP; Godfrey DI; Rossjohn J
Nat Commun; 2019 Nov; 10(1):5242. PubMed ID: 31748533
[TBL] [Abstract][Full Text] [Related]
8. Carbohydrate specificity of the recognition of diverse glycolipids by natural killer T cells.
Zajonc DM; Kronenberg M
Immunol Rev; 2009 Jul; 230(1):188-200. PubMed ID: 19594637
[TBL] [Abstract][Full Text] [Related]
9. Unappreciated diversity within the pool of CD1d-restricted T cells.
Pellicci DG; Uldrich AP
Semin Cell Dev Biol; 2018 Dec; 84():42-47. PubMed ID: 29183709
[TBL] [Abstract][Full Text] [Related]
10. Interview: glycolipid antigen presentation by CD1d and the therapeutic potential of NKT cell activation.
Kronenberg M
J Vis Exp; 2007; (10):635. PubMed ID: 18989407
[TBL] [Abstract][Full Text] [Related]
11. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
Wu L; Gabriel CL; Parekh VV; Van Kaer L
Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
[TBL] [Abstract][Full Text] [Related]
12. [Recognition of CD1d/glycolipid antigen complex by NKT cells and mechanisms in immune regulation].
Watarai H; Tashiro T; Chiba T; Taniguchi M
Tanpakushitsu Kakusan Koso; 2008 Sep; 53(12 Suppl):1584-9. PubMed ID: 21089371
[No Abstract] [Full Text] [Related]
13. Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.
Maricic I; Girardi E; Zajonc DM; Kumar V
J Immunol; 2014 Nov; 193(9):4580-9. PubMed ID: 25261475
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells.
Sullivan BA; Nagarajan NA; Wingender G; Wang J; Scott I; Tsuji M; Franck RW; Porcelli SA; Zajonc DM; Kronenberg M
J Immunol; 2010 Jan; 184(1):141-53. PubMed ID: 19949076
[TBL] [Abstract][Full Text] [Related]
15. Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation.
Im JS; Arora P; Bricard G; Molano A; Venkataswamy MM; Baine I; Jerud ES; Goldberg MF; Baena A; Yu KO; Ndonye RM; Howell AR; Yuan W; Cresswell P; Chang YT; Illarionov PA; Besra GS; Porcelli SA
Immunity; 2009 Jun; 30(6):888-98. PubMed ID: 19538930
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of NKT cell inhibition using the T-cell receptor-blocking anti-CD1d antibody 1B1.
Ying G; Wang J; Mallevaey T; Van Calenbergh S; Zajonc DM
J Biol Chem; 2019 Aug; 294(35):12947-12956. PubMed ID: 31296659
[TBL] [Abstract][Full Text] [Related]
17. Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.
Dasgupta S; Kumar V
Immunogenetics; 2016 Aug; 68(8):665-76. PubMed ID: 27405300
[TBL] [Abstract][Full Text] [Related]
18. Atypical natural killer T-cell receptor recognition of CD1d-lipid antigens.
Le Nours J; Praveena T; Pellicci DG; Gherardin NA; Ross FJ; Lim RT; Besra GS; Keshipeddy S; Richardson SK; Howell AR; Gras S; Godfrey DI; Rossjohn J; Uldrich AP
Nat Commun; 2016 Feb; 7():10570. PubMed ID: 26875526
[TBL] [Abstract][Full Text] [Related]
19. Interplay between carbohydrate and lipid in recognition of glycolipid antigens by natural killer T cells.
Pei B; Vela JL; Zajonc D; Kronenberg M
Ann N Y Acad Sci; 2012 Apr; 1253(1):68-79. PubMed ID: 22352829
[TBL] [Abstract][Full Text] [Related]
20. NKT and tolerance.
Diana J; Beaudoin L; Gautron AS; Lehuen A
Methods Mol Biol; 2011; 677():193-206. PubMed ID: 20941612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
